231 related articles for article (PubMed ID: 7829637)
1. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.
Yanagawa T; Hidaka Y; Guimaraes V; Soliman M; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jan; 80(1):41-5. PubMed ID: 7829637
[TBL] [Abstract][Full Text] [Related]
2. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
Kotsa K; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
[TBL] [Abstract][Full Text] [Related]
3. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Kouki T; Gardine CA; Yanagawa T; Degroot LJ
J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
[TBL] [Abstract][Full Text] [Related]
5. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans.
Chen QY; Nadell D; Zhang XY; Kukreja A; Huang YJ; Wise J; Svec F; Richards R; Friday KE; Vargas A; Gomez R; Chalew S; Lan MS; Tomer Y; Maclaren NK
J Clin Endocrinol Metab; 2000 Apr; 85(4):1545-9. PubMed ID: 10770195
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
Kouki T; Sawai Y; Gardine CA; Fisfalen ME; Alegre ML; DeGroot LJ
J Immunol; 2000 Dec; 165(11):6606-11. PubMed ID: 11086105
[TBL] [Abstract][Full Text] [Related]
7. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population.
Petrone A; Giorgi G; Galgani A; Alemanno I; Corsello SM; Signore A; Di Mario U; Nisticò L; Cascino I; Buzzetti R
Thyroid; 2005 Mar; 15(3):232-8. PubMed ID: 15785242
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children.
Iwama S; Ikezaki A; Kikuoka N; Kim HS; Matsuoka H; Yanagawa T; Sato H; Hoshi M; Sakamaki T; Sugihara S
Horm Res; 2005; 63(2):55-60. PubMed ID: 15640608
[TBL] [Abstract][Full Text] [Related]
9. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population.
Yanagawa T; Mangklabruks A; Chang YB; Okamoto Y; Fisfalen ME; Curran PG; DeGroot LJ
J Clin Endocrinol Metab; 1993 Jun; 76(6):1569-74. PubMed ID: 8501164
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease.
Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H
Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229
[TBL] [Abstract][Full Text] [Related]
11. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies.
Heward JM; Allahabadia A; Carr-Smith J; Daykin J; Cockram CS; Gordon C; Barnett AH; Franklyn JA; Gough SC
Clin Endocrinol (Oxf); 1998 Sep; 49(3):331-4. PubMed ID: 9861324
[TBL] [Abstract][Full Text] [Related]
12. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.
Bednarczuk T; Hiromatsu Y; Fukutani T; Jazdzewski K; Miskiewicz P; Osikowska M; Nauman J
Eur J Endocrinol; 2003 Jan; 148(1):13-8. PubMed ID: 12534352
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
Yung E; Cheng PS; Fok TF; Wong GW
Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
[TBL] [Abstract][Full Text] [Related]
14. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
Heward JM; Allahabadia A; Armitage M; Hattersley A; Dodson PM; Macleod K; Carr-Smith J; Daykin J; Daly A; Sheppard MC; Holder RL; Barnett AH; Franklyn JA; Gough SC
J Clin Endocrinol Metab; 1999 Jul; 84(7):2398-401. PubMed ID: 10404810
[TBL] [Abstract][Full Text] [Related]
15. Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes.
Ongagna JC; Sapin R; Pinget M; Belcourt A
Int J Exp Diabetes Res; 2002; 3(1):1-9. PubMed ID: 11900275
[TBL] [Abstract][Full Text] [Related]
16. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
[TBL] [Abstract][Full Text] [Related]
17. Analysis of immune regulatory genes in familial and sporadic Graves' disease.
Ban Y; Concepcion ES; Villanueva R; Greenberg DA; Davies TF; Tomer Y
J Clin Endocrinol Metab; 2004 Sep; 89(9):4562-8. PubMed ID: 15356063
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease.
Djilali-Saiah I; Schmitz J; Harfouch-Hammoud E; Mougenot JF; Bach JF; Caillat-Zucman S
Gut; 1998 Aug; 43(2):187-9. PubMed ID: 10189842
[TBL] [Abstract][Full Text] [Related]
19. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH
Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
[TBL] [Abstract][Full Text] [Related]
20. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
